TAVEXIA LIFECARE LIMITED
06 Nov 2026 12:00 AM
TAVEXIA LIFECARE LIMITED consolidated sales up 687.50% on year in Q3FY2026, net profit saw a strong growth of 150%,
TAVEXIA LIFECARE LIMITED share price remained flat to Rs 1.17 after the company`s net profit surged by 150% to Rs 0.4 crore, while revenue from operations increased sharply by 687.50% to Rs 5.04 crore in Q3FY26 over Q2FY26.
The market capitalization of Distributors industry group stocks on BSE stood at Rs 902.37 crore, rallying 25.48%. It has softened by 2.20% over last one week and eased lower by 4.83% in last one month while the market capitalization of TAVEXIA LIFECARE LIMITED has improved by 0.85% and 58.08% in the same period respectively.
Profit before tax (PBT) of TAVEXIA LIFECARE LIMITED stood at Rs 0.41 crore in Q3 FY26, nosediving by 144.09% year-on-year, and surging by 32.26% quarter-on-quarter. EBITDA came in at Rs 1 crore, tumbling by 207.21% YoY and expanding by 230.56% sequentially.
Total expenses surged 476.47% to Rs 5.88 crore in Q3FY26 over Q3FY25. During the quarter, employee benefits expense was at Rs 0.17 crore, soaring 41.67% YoY.
For the TTM ended FY26, revenue from operations soared by 513.12% to Rs 32.25 crore, while net profit plunged by 91.57% to Rs 0.21 crore, compared to previous TTM. EBITDA jumped by 198% to Rs 11.02 crore, and PBT collapsed by 94.67% to Rs 0.17 crore compared to previous TTM.
The company`s consolidated net cash flow from operating activities stood at Rs 14.34 crore in FY26, as against Rs 0.53 crore in FY25.
TAVEXIA LIFECARE LIMITED jumped 48.10% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 4.80% during the same period.
TAVEXIA LIFECARE LIMITED
05 Nov 2026 12:00 AM
TAVEXIA LIFECARE LIMITED consolidated sales up 687.50% on year in Q3FY2026, net profit soared by 150%,
TAVEXIA LIFECARE LIMITED share price declined by 0.85% to Rs 1.17. The Company`s net profit surged by 150% to Rs 0.4 crore, while revenue from operations increased sharply by 687.50% to Rs 5.04 crore in Q3FY26 over Q2FY26.
The market capitalization of Distributors industry group stocks on BSE stood at Rs 902.37 crore, surging by 25.48%. It has eased by 3.15% over last one week and dipped slightly by 3.83% in last one month while the market capitalization of TAVEXIA LIFECARE LIMITED has marginally improved by 1.75% and 58.08% in the same period respectively.
Profit before tax (PBT) of TAVEXIA LIFECARE LIMITED stood at Rs 0.41 crore in Q3 FY26, nosediving by 144.09% year-on-year, and expanding by 32.26% quarter-on-quarter. EBITDA came in at Rs 1 crore, tumbling by 207.21% YoY and jumping 230.56% sequentially.
Total expenses jumped by 476.47% to Rs 5.88 crore in Q3FY26 over Q3FY25. During the quarter, employee benefits expense was at Rs 0.17 crore, soaring 41.67% YoY.
For the TTM ended FY26, revenue from operations witnessed a strong growth of 513.12% to Rs 32.25 crore, while net profit tumbled by 91.57% to Rs 0.21 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 198% to Rs 11.02 crore, and PBT tanked by 94.67% to Rs 0.17 crore compared to previous TTM.
The company`s consolidated net cash flow from operating activities stood at Rs 14.34 crore in FY26, as against Rs 0.53 crore in FY25.
TAVEXIA LIFECARE LIMITED jumped 48.10% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 7.38% during the same period.
TAVEXIA LIFECARE LIMITED
30 Oct 2026 12:00 AM
Tavexia Lifecare to convene a board meeting to review financial results and consider fundraising,
Tavexia Lifecare Limited, formerly known as Sattva Sukun Lifecare Limited, will hold a board meeting on Wednesday, November 4, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, and to discuss a proposal for fund raising by way of a preferential issue, right issue, or other mode.
TAVEXIA LIFECARE LIMITED
10 Oct 2026 12:00 AM
Tavexia Lifecare submits regulatory certificate to BSE Limited from its RTA, Niche Technologies,
Tavexia Lifecare Limited, formerly known as Sattva Sukun Lifecare Limited, informed the BSE Limited that it is submitting a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and participants) Regulations, 2018, received from Niche Technologies Pvt. Ltd., the company’s Registrar and Share Transfer Agent, for the quarter ended September 30, 2026.
TAVEXIA LIFECARE LIMITED
26 Sep 2026 12:00 AM
Tavexia Lifecare closes trading window for insiders ahead of financial results announcement,
Tavexia Lifecare Limited, formerly Sattva Sukun Lifecare Limited, informed the BSE Limited that the trading window for dealing in shares of the company will be closed for all directors, promoters, designated persons, and their immediate relatives, effective October 1, 2026, until 48 hours after the announcement of unaudited financial results for the quarter and half year ended September 30, 2026.
Subscribe for our
newsletter
newsletter
HSL Mobile App